CYTOKINETICS, INCORPORATED Debt Securities, Available-for-sale, Noncurrent
CYTOKINETICS, INCORPORATED (CYTK) had Debt Securities, Available-for-sale, Noncurrent of $538.32 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent · last filed 2026-08-06
- 2026-06-30: Debt Securities, Available-for-sale, Noncurrent $538.32M.
- 2026-03-31: Debt Securities, Available-for-sale, Noncurrent $254.72M.
- 2025-12-31: Debt Securities, Available-for-sale, Noncurrent $335.05M.
- 2025-09-30: Debt Securities, Available-for-sale, Noncurrent $288.82M.
| Period end | Debt Securities, Available-for-sale, Noncurrent |
|---|---|
| 2026-06-30 | $538.32M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $254.72M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $335.05M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $288.82M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $178.20M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $150.69M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $145.06M 10-K · filed 2026-02-26 |
| 2024-09-30 | $269.17M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $305.36M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $15.38M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $40.53M 10-K · filed 2025-02-27 |
| 2023-09-30 | $15.47M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $26.87M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $40.41M 10-Q · filed 2023-05-05 |
| 2022-12-31 | $46.71M 10-K · filed 2024-02-28 |
| 2022-09-30 | $28.54M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $10.67M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $77.08M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $152.05M 10-K · filed 2023-03-01 |
| 2020-12-31 | $36.95M 10-K · filed 2022-02-25 |
| 2016-03-31 | $5.14M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $179.00K 10-Q · filed 2016-05-05 |
| 2015-06-30 | $3.04M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $9.65M 10-Q · filed 2015-05-04 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-03 |
| 2011-12-31 | $0.00 10-K · filed 2012-03-13 |
| 2011-09-30 | $0.00 10-Q · filed 2011-11-04 |
| 2011-06-30 | $0.00 10-Q · filed 2011-08-04 |
| 2010-12-31 | $1.21M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |